List of Excipients in API alendronate sodium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alendronate sodium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | FOSAMAX | alendronate sodium | 0006-0031 | ANHYDROUS LACTOSE | |
| Merck Sharp & Dohme Corp | FOSAMAX | alendronate sodium | 0006-0031 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | FOSAMAX | alendronate sodium | 0006-0031 | CROSCARMELLOSE SODIUM | |
| Merck Sharp & Dohme Corp | FOSAMAX | alendronate sodium | 0006-0031 | MAGNESIUM STEARATE | |
| Mission Pharmacal Company | BINOSTO | alendronate sodium | 0178-0101 | ACESULFAME POTASSIUM | |
| Mission Pharmacal Company | BINOSTO | alendronate sodium | 0178-0101 | ANHYDROUS CITRIC ACID | |
| Mission Pharmacal Company | BINOSTO | alendronate sodium | 0178-0101 | MONOSODIUM CITRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing alendronate sodium
Detailed excipient profiles for alendronate sodium
Excipient focus: ACESULFAME POTASSIUM
alendronate sodium drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mission Pharmacal Company | alendronate sodium | 0178-0101 |
| ASCEND Therapeutics | alendronate sodium | 17139-400 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ANHYDROUS CITRIC ACID
alendronate sodium drug variants containing ANHYDROUS CITRIC ACID
alendronate sodium drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
alendronate sodium drug variants containing ANHYDROUS LACTOSE
alendronate sodium drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYTOLUENE
alendronate sodium drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | alendronate sodium and cholecalciferol | 0006-0710 |
| Physicians Total Care Inc | alendronate sodium and cholecalciferol | 54868-5480 |
| Organon LLC | alendronate sodium and cholecalciferol | 78206-137 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
alendronate sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
alendronate sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
alendronate sodium drug variants containing CROSCARMELLOSE SODIUM
alendronate sodium drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: GELATIN
alendronate sodium drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | alendronate sodium and cholecalciferol | 0006-0710 |
| Physicians Total Care Inc | alendronate sodium and cholecalciferol | 54868-5480 |
| Organon LLC | alendronate sodium and cholecalciferol | 78206-137 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing GELATIN
Excipient focus: LACTOSE MONOHYDRATE
alendronate sodium drug variants containing LACTOSE MONOHYDRATE
alendronate sodium drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
alendronate sodium drug variants containing MAGNESIUM STEARATE
alendronate sodium drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
alendronate sodium drug variants containing MANNITOL
alendronate sodium drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
alendronate sodium drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | alendronate sodium and cholecalciferol | 0006-0710 |
| Physicians Total Care Inc | alendronate sodium and cholecalciferol | 54868-5480 |
| Organon LLC | alendronate sodium and cholecalciferol | 78206-137 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHYLPARABEN
alendronate sodium drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | alendronate sodium | 0054-0282 |
| TAGI Pharma Inc | alendronate sodium | 51224-301 |
| ANI Pharmaceuticals Inc | alendronate sodium | 70954-264 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing METHYLPARABEN
Excipient focus: MONOSODIUM CITRATE
alendronate sodium drug variants containing MONOSODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mission Pharmacal Company | alendronate sodium | 0178-0101 |
| ASCEND Therapeutics | alendronate sodium | 17139-400 |
| Radius Health Inc | alendronate sodium | 70539-400 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing MONOSODIUM CITRATE
Excipient focus: POVIDONE K30
alendronate sodium drug variants containing POVIDONE K30
alendronate sodium drug variants not containing POVIDONE K30
Excipient focus: PROPYLPARABEN
alendronate sodium drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | alendronate sodium | 0054-0282 |
| TAGI Pharma Inc | alendronate sodium | 51224-301 |
| ANI Pharmaceuticals Inc | alendronate sodium | 70954-264 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
alendronate sodium drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | alendronate sodium | 0054-0282 |
| TAGI Pharma Inc | alendronate sodium | 51224-301 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SACCHARIN SODIUM
Excipient focus: SACCHARIN SODIUM MONOHYDRATE
alendronate sodium drug variants containing SACCHARIN SODIUM MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | alendronate sodium | 70954-264 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SACCHARIN SODIUM MONOHYDRATE
Excipient focus: SILICON DIOXIDE
alendronate sodium drug variants containing SILICON DIOXIDE
alendronate sodium drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ALUMINIUM SILICATE
alendronate sodium drug variants containing SODIUM ALUMINIUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | alendronate sodium and cholecalciferol | 54868-5480 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SODIUM ALUMINIUM SILICATE
Excipient focus: SODIUM ALUMINOSILICATE
alendronate sodium drug variants containing SODIUM ALUMINOSILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | alendronate sodium and cholecalciferol | 0006-0710 |
| Organon LLC | alendronate sodium and cholecalciferol | 78206-137 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SODIUM ALUMINOSILICATE
Excipient focus: SODIUM BICARBONATE
alendronate sodium drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mission Pharmacal Company | alendronate sodium | 0178-0101 |
| ASCEND Therapeutics | alendronate sodium | 17139-400 |
| Radius Health Inc | alendronate sodium | 70539-400 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CARBONATE
alendronate sodium drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mission Pharmacal Company | alendronate sodium | 0178-0101 |
| ASCEND Therapeutics | alendronate sodium | 17139-400 |
| Radius Health Inc | alendronate sodium | 70539-400 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SODIUM CARBONATE
Excipient focus: SODIUM CITRATE
alendronate sodium drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | alendronate sodium | 0054-0282 |
| TAGI Pharma Inc | alendronate sodium | 51224-301 |
| ANI Pharmaceuticals Inc | alendronate sodium | 70954-264 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
alendronate sodium drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
alendronate sodium drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
alendronate sodium drug variants containing STARCH, CORN
alendronate sodium drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
alendronate sodium drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mission Pharmacal Company | alendronate sodium | 0178-0101 |
| ASCEND Therapeutics | alendronate sodium | 17139-400 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SUCRALOSE
Excipient focus: SUCROSE
alendronate sodium drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | alendronate sodium and cholecalciferol | 0006-0710 |
| Physicians Total Care Inc | alendronate sodium and cholecalciferol | 54868-5480 |
| Organon LLC | alendronate sodium and cholecalciferol | 78206-137 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing SUCROSE
Excipient focus: WATER
alendronate sodium drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Radius Health Inc | alendronate sodium | 70539-400 |
| ANI Pharmaceuticals Inc | alendronate sodium | 70954-264 |
| >Company | >Ingredient | >NDC |
alendronate sodium drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
